Protective effect of phloroglucinol against myocardial ischaemia-reperfusion injury is related to inhibition of myeloperoxidase activity and inflammatory cell infiltration

Clinical and Experimental Pharmacology and Physiology

Volumn 38, Issue 1, 2011, Pages 27-33

  Li, Ting Ting ^a   Zhang, Yi Shuai ^a   He, Lan ^a   Li, Nian Sheng ^a   Peng, Jun ^a,b   Li, Yuan Jian ^a,b  

^a Department of Pharmacology ^*  (China)

^b CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

Apoptosis; Catalase; Infarct size; Ischaemia reperfusion injury; Myeloperoxidase; Phloroglucinol

Indexed keywords

CARBOXYMETHYLCELLULOSE; CASPASE 3; CATALASE; CREATINE KINASE; MYELOPEROXIDASE; PHLOROGLUCINOL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; APOPTOSIS; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; HEART INFARCTION; HEART INFARCTION SIZE; HEART MUSCLE ISCHEMIA; HEART PROTECTION; INFLAMMATION; MALE; NONHUMAN; PROTEIN CONTENT; RAT; REPERFUSION INJURY;

ANIMALS; APOPTOSIS; CARDIOTONIC AGENTS; DRUG EVALUATION, PRECLINICAL; ENZYME INHIBITORS; INFLAMMATION; MALE; MYOCARDIAL INFARCTION; MYOCARDIAL REPERFUSION INJURY; MYOCARDIUM; NEUTROPHIL INFILTRATION; PEROXIDASE; PHLOROGLUCINOL; RATS; RATS, SPRAGUE-DAWLEY;

EID: 78650665010     PISSN: 03051870     EISSN: 14401681     Source Type: Journal    
DOI: 10.1111/j.1440-1681.2010.05457.x     Document Type: Article

References (30)

1. Quintana M, Kahan T, Hjemdahl P. Pharmacological prevention of reperfusion injury in acute myocardial infarction. A potential role for adenosine as a therapeutic agent. Am. J. Cardiovasc. Drugs 2004; 4: 159-67.
2. Luo Y, Li GL, Pan YZ, Zhou SF. Determinants and prognostic implications of reperfusion injury during primary percutaneous coronary intervention in Chinese patients with acute myocardial infarction. Clin. Cardiol. 2009; 32: 148-53.
3. Zhao ZQ. Oxidative stress-elicited myocardial apoptosis during reperfusion. Curr. Opin. Pharmacol. 2004; 4: 159-65.
4. Carreira RS, Monteiro P, Kowaltowski AJ, Goncalves LM, Providencia LA. Nicorandil protects cardiac mitochondria against permeability transition induced by ischemia-reperfusion. J. Bioenerg. Biomembr. 2008; 40: 95-102.
5. Carter J, Buerke U, Rossner E et al. Anti-inflammatory actions of aprotinin provide dose-dependent cardioprotection from reperfusion injury. Br. J. Pharmacol. 2008; 155: 93-102.
6. Vinten-Johansen J. Involvement of neutrophils in the pathogenesis of lethal myocardial reperfusion injury. Cardiovasc. Res. 2004; 61: 481-97.
7. Nahrendorf M, Sosnovik D, Chen JW et al. Activatable magnetic resonance imaging agent reports myeloperoxidase activity in healing infarcts and noninvasively detects the antiinflammatory effects of atorvastatin on ischemia-reperfusion injury. Circulation 2008; 117: 1153-60.
8. Rees MD, Bottle SE, Fairfull-Smith KE et al. Inhibition of myeloperoxidase-mediated hypochlorous acid production by nitroxides. Biochem. J. 2009; 421: 79-86.
9. Klebanoff SJ. Myeloperoxidase: Friend and foe. J. Leukoc. Biol. 2005; 77: 598-625.
10. Hirche TO, Gaut JP, Heinecke JW, Belaaouaj A. Myeloperoxidase plays critical roles in killing Klebsiella pneumoniae and inactivating neutrophil elastase: Effects on host defense. J. Immunol. 2005; 174: 1557-65.
11. Liu HR, Tao L, Gao E et al. Rosiglitazone inhibits hypercholesterolaemia-induced myeloperoxidase upregulation - a novel mechanism for the cardioprotective effects of PPAR agonists. Cardiovasc. Res. 2009; 81: 344-52.
12. Kang KA, Lee KH, Chae S et al. Cytoprotective effect of phloroglucinol on oxidative stress induced cell damage via catalase activation. J. Cell. Biochem. 2006; 97: 609-20.
13. Chassany O, Bonaz B, Bruley DESVS et al. Acute exacerbation of pain in irritable bowel syndrome: Efficacy of phloroglucinol/trimethylphloroglucinol. A randomized, double-blind, placebo-controlled study. Aliment. Pharmacol. Ther. 2007; 25: 1115-23.
14. Sasaki D, Kido A, Yoshida Y. Effect of antispasmodic drugs on the colonic motility. Part II. Clinical study in man. Int. J. Clin. Pharmacol. Ther. Toxicol. 1984; 22: 338-41.
15. Nelson RE, Fessler LI, Takagi Y et al. Peroxidasin: A novel enzyme-matrix protein of Drosophila development. EMBO J. 1994; 13: 3438-47.
16. Lin KW, Huang AM, Tu HY et al. Phloroglucinols inhibit chemical mediators and xanthine oxidase, and protect cisplatin-induced cell death by reducing reactive oxygen species in normal human urothelial and bladder cancer cells. J. Agric. Food. Chem. 2009; 57: 8782-7.
17. Jafri W, Yakoob J, Hussain S, Jafri N, Islam M. Phloroglucinol in irritable bowel syndrome. J. Pak. Med. Assoc 2006; 56: 5-8.
18. Reagan-Shaw S, Nihal M, Ahmad N. Dose translation from animal to human studies revisited. FASEB J. 2008; 22: 659-61.
19. Arnal E, Miranda M, Johnsen-Soriano S et al. Beneficial effect of docosahexanoic acid and lutein on retinal structural, metabolic, and functional abnormalities in diabetic rats. Curr. Eye Res. 2009; 34: 928-38.
20. Antal-Szalmas P, Strijp JA, Weersink AJ, Verhoef J, Van Kessel KP. Quantitation of surface CD14 on human monocytes and neutrophils. J. Leukoc. Biol. 1997; 61: 721-8.
21. Robin E, Guzy RD, Loor G et al. Oxidant stress during simulated ischemia primes cardiomyocytes for cell death during reperfusion. J. Biol. Chem. 2007; 282: 19133-43.
22. Korge P, Ping P, Weiss JN. Reactive oxygen species production in energized cardiac mitochondria during hypoxia/reoxygenation: Modulation by nitric oxide. Circ. Res. 2008; 103: 873-80.
23. Li C, Jackson RM. Reactive species mechanisms of cellular hypoxia-reoxygenation injury. Am. J. Physiol. Cell Physiol. 2002; 282: C227-41.
24. Kawai Y, Kiyokawa H, Kimura Y et al. Hypochlorous acid-derived modification of phospholipids: Characterization of aminophospholipids as regulatory molecules for lipid peroxidation. Biochemistry 2006; 45: 14201-11.
25. Osipov RM, Bianchi C, Feng J et al. Effect of hypercholesterolemia on myocardial necrosis and apoptosis in the setting of ischemia-reperfusion. Circulation 2009; 120: S22-30.
26. Wolkart G, Kaber G, Kojda G, Brunner F. Role of endogenous hydrogen peroxide in cardiovascular ischaemia/reperfusion function: Studies in mouse hearts with catalase-overexpression in the vascular endothelium. Pharmacol. Res. 2006; 54: 50-6.
27. Yang J, Jiang H, Yang J et al. Valsartan preconditioning protects against myocardial ischemia-reperfusion injury through TLR4/NF-kappaB signaling pathway. Mol. Cell. Biochem. 2009; 330: 39-46.
28. Akhlaghi M, Bandy B. Mechanisms of flavonoid protection against myocardial ischemia-reperfusion injury. J. Mol. Cell. Cardiol. 2009; 46: 309-17.
29. Kim H, Roh H, Lee HJ et al. Determination of phloroglucinol in human plasma by high-performance liquid chromatography-mass spectrometry. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 2003; 792: 307-12.
30. Zhuang Y, Zhu X, Huang LL. The effect of phloroglucinol on pain in first-trimester surgical abortion: A double-blind randomized controlled study. Contraception 2010; 81: 157-60.